Peak Pharmaceuticals, Inc. reported earnings results for the first quarter ended December 31, 2022. For the first quarter, the company reported net loss was USD 0.112242 million compared to USD 0.059355 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | 0.00% | 0.00% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+13.55% | 3,200B | |
+13.86% | 87.43B | |
+8.19% | 79.69B | |
-11.45% | 56.79B | |
+20.68% | 47.14B | |
+28.56% | 46.62B | |
-26.77% | 45.5B | |
+77.11% | 42.31B | |
-5.36% | 25.81B |
- Stock Market
- Equities
- RMHI Stock
- News Retrieve Medical Holdings Inc
- Peak Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022